• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
OTC Pharmaceuticals Market Report 2014 Product Image

OTC Pharmaceuticals Market Report 2014

  • Published: April 2014
  • Region: United Kingdom
  • 104 Pages
  • Key Note Publications Ltd

FEATURED COMPANIES

  • Bayer Plc
  • Glaxosmithkline Plc
  • John Wyeth & Brother Ltd
  • Johnson & Johnson Ltd
  • Novartis UK Ltd
  • MORE

This Market Report analyses the over-the-counter (OTC) pharmaceuticals market in Great Britain. This includes medicines/products that can be obtained from a registered healthcare professional without a prescription, such as pain relievers, cough and cold remedies, sleeping aids, anti-fungal cream, and other products approved for use as a self-medication.

The market for OTC pharmaceuticals rebounded following the recent economic downturn and the sector grew by 3.5% and 2.1% in 2012/2013 and 2013/2014, respectively. By sector, analgesics represented the largest category, accounting for 21.2% of total sales of OTC products in 2013/2014. The second-largest sector within the OTC pharmaceuticals market was skincare treatment (19.3%), followed by cough, cold and sore-throat remedies (17.1%).

Within the market for analgesics, adult oral analgesics is the largest subsector, making up 64.8% of the total sales of analgesics in the year ending February 2014. The largest subsector in the skincare treatment market is foot care products, which has been growing over the past few years. Demand for cough, cold and sore-throat remedies is influenced by seasonal and weather conditions.

The READ MORE >

Executive Summary

1. Market Definition

REPORT COVERAGE
Pharmacy-Only Medicines
General Sales List Medicines
MARKET SECTORS.
Analgesics
Cough, Cold and Sore-Throat Remedies.
Skincare Treatments
Gastro-Intestinal Remedies
Other Over-the-Counter Products
MARKET TRENDS.
Reform of the UK Healthcare System
Self Care and Self-Medication
Trends in Consumer Purchasing Behaviour
ECONOMIC TRENDS
Table 1.1: UK Economic Trends (000, £m, %, million and £), 2009-2013
MARKET POSITION
The UK
Table 1.2: Household Expenditure on Pharmaceutical Products as a Percentage
of Total Consumption Expenditure in the UK
at Current Prices (£m and %), 2009-2012
Overseas.
Table 1.3: Average Annual Expenditure on Pharmaceuticals
Per Capita in Selected Countries ($), 2011

2. Market Size

THE TOTAL MARKET
Table 2.1: The Total Market for OTC Pharmaceuticals in Great Britain by Value
(£m at rsp), Years Ending February 2010-2014
Figure 2.1: The Total Market for OTC Pharmaceuticals in Great Britain by Value
(£m at rsp), Years Ending February 2010-2014
BY MARKET SECTOR.
Figure 2.1: The Total Market for OTC Pharmaceuticals in Great Britain by Sector
by Value Share (%), Year Ending February 2014.
Analgesics
Table 2.2: The Analgesics Sector in Great Britain by Subsector by Value (£m at rsp),
Years Ending February 2010-2014
Figure 2.3: The Analgesics Sector in Great Britain by Value
(£m at rsp), Years Ending February 2010-2014
Skincare Treatment
Table 2.3: The Skincare Treatment Sector in Great Britain
by Subsector by Value (£m at rsp), Years Ending February 2010-2014.
Figure 2.4: The Skincare Treatment Sector in Great Britain
by Value (£m at rsp), Years Ending February 2010-2014.
Cough, Cold and Sore-Throat Remedies.
Table 2.4: The Cough, Cold and Sore-Throat Remedies Sector
in Great Britain by Subsector by Value (£m at rsp),
Years Ending February 2010-2014
Figure 2.5: The Cough, Cold and Sore-Throat Remedies Sector in Great Britain
by Value (£m at rsp), Years Ending February 2010-2014.
Gastro-Intestinal Remedies
Table 2.5: The Gastro-Intestinal Remedies Sector in Great Britain by Subsector
by Value (£m at rsp), Years Ending February 2010-2014.
Figure 2.6: The Gastro-Intestinal Remedies Sector in Great Britain by Value
(£m at rsp), Years Ending February 2010-2014
Other Over-the-Counter Products
Table 2.6: Other OTC Products Sector in Great Britain
by Subsector by Value (£m at rsp), Years Ending February 2010-2014.
Figure 2.7: Other OTC Products Sector in Great Britain
by Value (£m at rsp), Years Ending February 2010-2014.
OVERSEAS TRADE
Table 2.7: UK Exports and Imports of Basic Pharmaceutical Products
and Pharmaceutical Preparations (£m), 2009-2013.
Figure 2.8: UK Exports and Imports of Basic Pharmaceutical Products
and Pharmaceutical Preparations (£m), 2009-2013.

3. Industry Background

RECENT HISTORY.
NUMBER OF COMPANIES.
Table 3.1: Number of UK VAT- and/or PAYE-Based Enterprises Engaged
in the Manufacture of Basic Pharmaceutical Products and Pharmaceutical
Preparations by Turnover Sizeband (£000 and number), 2013
Figure 3.1: Number of UK VAT- and/or PAYE-Based Enterprises Engaged
in the Manufacture of Basic Pharmaceutical Products and Pharmaceutical
Preparations by Turnover Sizeband (£000 and %), 2013.
EMPLOYMENT
Table 3.2: Number of UK VAT- and/or PAYE-Based Enterprises Engaged
in the Manufacture of Basic Pharmaceutical Products and Pharmaceutical
Preparations by Employment Sizeband, 2013
Figure 3.2: Number of UK VAT- and/or PAYE-Based Enterprises Engaged
in the Manufacture of Basic Pharmaceutical Products and Pharmaceutical
Preparations by Employment Sizeband (number and %), 2013.
REGIONAL VARIATIONS IN THE MARKETPLACE.
DISTRIBUTION.
Pharmacies.
Table 3.3: Number of Community Pharmacies in Contract
With Primary Care Trusts, 2008/2009-2012/2013.
Figure 3.3: Number of Community Pharmacies in Contract
With Primary Care Trusts, 2008/2009-2012/2013.
Supermarkets and Other Retailers.
HOW ROBUST IS THE MARKET?.
LEGISLATION.
KEY TRADE ASSOCIATIONS
Association of British Pharmaceutical Industry .
Association of the European Self-Medication Industry
British Association of Pharmaceutical Wholesalers.
European Association of Pharmaceutical Full-Line Wholesalers
Proprietary Association of Great Britain.

4. Competitor Analysis

THE MARKETPLACE
MARKET LEADERS.
Bayer HealthCare.
GlaxoSmithKline PLC.
Johnson & Johnson Ltd.
Novartis UK Ltd.
Reckitt Benckiser Group PLC
John Wyeth & Brother Ltd.
OUTSIDE SUPPLIERS
MARKETING ACTIVITY.
Main Media Advertising Expenditure
Table 4.1: Main Media Advertising Expenditure on OTC Pharmaceuticals by Sector
by Selected Brand (£), Year Ending September 2013.

5. Strengths, Weaknesses, Opportunities and Threats

STRENGTHS
WEAKNESSES
OPPORTUNITIES.
THREATS.

6. Buying Behaviour

CONSUMER PENETRATION.
Table 6.1: Use of Selected Over-the-Counter Pharmaceuticals
in the Last 12 Months by Sex (% of adults), Year Ending December 2013
CUSTOMER PROFILE.
Table 6.2: Consumer Attitudes Towards the Usage of OTC Pharmaceuticals
(% of respondents), 2010 and 2014.
Purchasing Over-the-Counter Medicines
Table 6.3: Adults Who Stock Up On OTC Products and Those Who Only Buy When
the Need Arises (% of respondents), 2014.
Availability of OTC Products and Concerns About Side Effects
Table 6.4: Adults Who Would Like a Wider Range of OTC Products and Those
Worried About Side Effects (% of respondents), 2014
Advice on OTC Products from Pharmacists and GPs.
Table 6.5: Adults Who Have Sought Advice About OTC Products from a Pharmacist
and Those Who Have Been Advised to Buy Them by a GP (% of respondents),
2014
Self-Medication for Reasons of Cost and Convenience
Table 6.6: Adults Who Have Been Encouraged to Use OTC Medicines for Reasons
of Cost or Convenience (% of respondents), 2014
Effectiveness of Over-the-Counter Medicines Compared with Alternative
Medicines.
Table 6.7: Adults Who Believe that Alternative Medicines
Are as Effective as OTC Medicines (% of respondents), 2014.
Brand Names.
Table 6.8: Adults Who Are More Likely to Buy Brand Names as Opposed
to Own-Brands (% of respondents), 2014.

7. Current Issues

MAJOR PHARMACEUTICAL COMPANIES SCALING BACK
PRESCRIPTION CHARGES CONTINUE TO RISE .
GP SERVICE UNDER SIGNIFICANT PRESSURE .
NEW GUIDANCE FOR ADDICTION TO OTC MEDICINES

8. The Global Market

INTRODUCTION
THE EUROPEAN MARKET.
Total 8.1: The Selected European Non-Prescription Pharmaceutical Market by Value
at Consumer Prices (€m and %), 2010-2012.

9. Forecasts

GENERAL ECONOMIC FORECASTS.
Table 9.1: Economic Forecasts (000, % and million), 2014-2018
FORECASTS 2015 TO 2019
Table 9.2: The Forecast Total Market for OTC Pharmaceuticals
in Great Britain by Value (£m at rsp), Years Ending February 2015-2019
Figure 9.1: The Forecast Total Market for OTC Pharmaceuticals
in Great Britain by Value (£m at rsp), Years Ending February 2015-2019
MARKET GROWTH
Figure 9.2: Growth in the Total Market for OTC Pharmaceuticals
in Great Britain by Value (£m at rsp), Years Ending February 2010-2019
FUTURE TRENDS.
Population Ageing.
Product Innovation .

10. Company Profiles
BAYER PLC
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON LTD
JOHN WYETH & BROTHER LTD
NOVARTIS UK LTD
RECKITT BENCKISER GROUP PLC

11. Further Sources

Associations.
Publications.
General Sources.
Government Publications
Other Sources.
Understanding Consumer Survey Data
Number, Profile, Penetration
Social Grade.
Standard Region

- Bayer Plc
- Glaxosmithkline Plc
- John Wyeth & Brother Ltd
- Johnson & Johnson Ltd
- Novartis UK Ltd
- Reckitt Benckiser Group Plc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos